3rd Quarter - Report

PODESTA GROUP, INC. for EMD SERONO INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness 2008 Medicare Bill S. 3101, Medicare Improvements for Patients and Providers Act of 2008 H.R.6331, Medicare Improvements for Patients and Providers Act of 2008 H.R. 1424, Emergency Economic Stabilization Act of 2008

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN New —
SHARON COHEN —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA)

Bills named: S. 2662 (110th), H.R. 4 (110th), S. 2029 (110th), S. 1376 (110th), H.R. 3162 (110th), H.R. 5480 (110th), H.R. 1424 (110th), S. 3101 (110th), H.R. 2606 (110th), S. 3 (110th), H.R. 6331 (110th)

Pharmacy PHA

S. 877, Controlling the Abuse of Prescriptions Act of 2007 Drug importation H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
COURTNEY HAGEN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1695 (110th), S. 877 (110th), S. 1505 (110th), H.R. 5629 (110th), S. 2029 (110th), H.R. 1956 (110th), H.R. 1038 (110th), S. 623 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008 H. R. 1908, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
SHARON COHEN —
COURTNEY HAGEN —
CLAUDIA JAMES —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 3600 (110th), H.R. 1908 (110th), S. 1145 (110th)

Budget/Appropriations BUD

LHHS Appropriations Drug importation House Concurrent Resolution 312 House Budget Resolution Senate Concurrent Resolution 70 Senate Budget Resolution Comparative Effectiveness H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009

LobbyistCovered position, as disclosed
SHARON COHEN —
RANDALL GERARD —
ANTHONY PODESTA —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 2638 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.